[Form 4] SkyWater Technology, Inc. Insider Trading Activity
Rhea-AI Filing Summary
SkyWater Technology CEO and director sold 24,936 shares of common stock in a reported transaction at a weighted-average price of $12.242 per share, executed in multiple trades priced between $12.15 and $12.45. After the sale the reporting person beneficially owned 540,529 shares, reported as direct ownership. The Form 4 shows a standard Section 16 disclosure of an insider sale and includes an attorney-in-fact signature; no options, warrants, or other derivative transactions are reported.
Positive
- None.
Negative
- Insider sale reported: CEO/director sold 24,936 shares at a weighted-average price of $12.242.
- No derivative transactions disclosed: only a direct sale is reported, providing limited transparency on other compensation instruments.
Insights
TL;DR: Insider sale of modest size relative to holdings, likely not material to company valuation absent other information.
The CEO and director reported a sale of 24,936 shares at a weighted-average price of $12.242, reducing direct beneficial ownership to 540,529 shares. The transaction code indicates a sale; there are no derivative transactions disclosed. As reported, the sale represents a small percentage of the reporting person’s post-transaction holdings and does not by itself reveal change in company fundamentals, revenue or earnings. Without accompanying corporate events or filings, this disclosure is routine director/officer activity under Section 16.
TL;DR: Routine insider sell disclosure; governance processes appear followed but context for the sale is not provided.
The Form 4 lists the reporting person as both CEO and director and shows a direct sale of 24,936 shares at a weighted-average price of $12.242, with remaining direct ownership of 540,529 shares. The form is properly signed by an attorney-in-fact. The filing does not state any Rule 10b5-1 plan or other rationale, so governance reviewers will note compliance with disclosure rules but cannot infer intent or policy adherence beyond the reported facts.